FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022220426> ?p ?o ?g. }

• W2022220426 endingPage "385" @default.
• W2022220426 startingPage "379" @default.
• W2022220426 abstract "Using matched-pair analysis, we compared two popular methods of stem cell mobilization in 24 advanced-stage breast cancer patients who underwent two consecutive mobilizing procedures as part of a tandem transplant protocol. For the first cycle, 10 microg/kg/day granulocyte colony-stimulating factor (G-CSF) was given and apheresis commenced on day 4 and continued for < or =5 days (median 3 days). One week after the first cycle of apheresis, 4000 mg/m2 cyclophosphamide, 400 mg/m2 etoposide, and 10 microg/kg G-CSF were administered for < or =16 days (cycle 2). Apheresis was initiated when the white blood cell (WBC) count exceeded 5000 cells/microL and continued for < or =5 days (median 3 days). Mean values of peripheral blood WBC (31,700+/-3200 vs. 30,700+/-3300/microL) were not significantly different between cycles 1 and 2. Mean number of mononuclear cells (MNC) collected per day was slightly greater with G-CSF mobilization than with the combination of chemotherapy and G-CSF (2.5+/-0.21x10(8) vs. 1.8+/-0.19x10(8) cells/kg). Mean daily CD34+ cell yield, however, was nearly six times higher (12.9+/-4.4 vs. 2.2+/-0.5x10(6)/kg; p = 0.01) with chemotherapy plus G-CSF. With G-CSF alone, 13% of aphereses reached the target dose of 5x10(6) CD34+ cells/kg in one collection vs. 57% with chemotherapy plus G-CSF. Transfusions of red blood cells or platelets were necessary in 18 of 24 patients in cycle 2. Three patients were hospitalized with fever for a median of 3 days after cycle 2. No patients received transfusions or required hospitalization during mobilization with G-CSF alone. Resource utilization (cost of drugs, aphereses, cryopreservation, transfusions, hospitalization) was calculated comparing the median number of collections to obtain a target CD34+ cell dose of 5x10(6) cells/kg: four using G-CSF vs. one using the combination in this data set. Resources for G-CSF mobilization cost $7326 vs. $8693 for the combination, even though more apheresis procedures were performed using G-CSF mobilization. The cost of chemotherapy administration, more doses of G-CSF, transfusions, and hospitalizations caused cyclophosphamide, etoposide, and G-CSF to be more expensive than G-CSF alone. A less toxic and less expensive treatment than cyclophosphamide, etoposide, and G-CSF is needed to be more cost-effective than G-CSF alone for peripheral blood progenitor cell mobilization." @default.
• W2022220426 created "2016-06-24" @default.
• W2022220426 creator A5000357804 @default.
• W2022220426 creator A5001440882 @default.
• W2022220426 creator A5010208681 @default.
• W2022220426 creator A5016644198 @default.
• W2022220426 creator A5032529043 @default.
• W2022220426 creator A5039026594 @default.
• W2022220426 creator A5066792408 @default.
• W2022220426 creator A5068339648 @default.
• W2022220426 creator A5081552297 @default.
• W2022220426 date "1999-12-01" @default.
• W2022220426 modified "2023-09-25" @default.
• W2022220426 title "Matched-pair analysis of hematopoietic progenitor cell mobilization using G-CSF vs. cyclophosphamide, etoposide, and G-CSF: Enhanced CD34+ cell collections are not necessarily cost-effective" @default.
• W2022220426 doi "https://doi.org/10.1016/s1083-8791(99)70014-5" @default.
• W2022220426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10595815" @default.
• W2022220426 hasPublicationYear "1999" @default.
• W2022220426 type Work @default.
• W2022220426 sameAs 2022220426 @default.
• W2022220426 citedByCount "18" @default.
• W2022220426 countsByYear W20222204262013 @default.
• W2022220426 countsByYear W20222204262015 @default.
• W2022220426 crossrefType "journal-article" @default.
• W2022220426 hasAuthorship W2022220426A5000357804 @default.
• W2022220426 hasAuthorship W2022220426A5001440882 @default.
• W2022220426 hasAuthorship W2022220426A5010208681 @default.
• W2022220426 hasAuthorship W2022220426A5016644198 @default.
• W2022220426 hasAuthorship W2022220426A5032529043 @default.
• W2022220426 hasAuthorship W2022220426A5039026594 @default.
• W2022220426 hasAuthorship W2022220426A5066792408 @default.
• W2022220426 hasAuthorship W2022220426A5068339648 @default.
• W2022220426 hasAuthorship W2022220426A5081552297 @default.
• W2022220426 hasBestOaLocation W20222204261 @default.
• W2022220426 hasConcept C10205521 @default.
• W2022220426 hasConcept C109159458 @default.
• W2022220426 hasConcept C126322002 @default.
• W2022220426 hasConcept C126894567 @default.
• W2022220426 hasConcept C137061746 @default.
• W2022220426 hasConcept C141071460 @default.
• W2022220426 hasConcept C185592680 @default.
• W2022220426 hasConcept C201750760 @default.
• W2022220426 hasConcept C202751555 @default.
• W2022220426 hasConcept C2776694085 @default.
• W2022220426 hasConcept C2776738589 @default.
• W2022220426 hasConcept C2776755627 @default.
• W2022220426 hasConcept C2777371436 @default.
• W2022220426 hasConcept C2777767877 @default.
• W2022220426 hasConcept C2778119113 @default.
• W2022220426 hasConcept C2778488018 @default.
• W2022220426 hasConcept C2779171977 @default.
• W2022220426 hasConcept C28328180 @default.
• W2022220426 hasConcept C54355233 @default.
• W2022220426 hasConcept C55493867 @default.
• W2022220426 hasConcept C71924100 @default.
• W2022220426 hasConcept C86803240 @default.
• W2022220426 hasConcept C89560881 @default.
• W2022220426 hasConcept C90924648 @default.
• W2022220426 hasConceptScore W2022220426C10205521 @default.
• W2022220426 hasConceptScore W2022220426C109159458 @default.
• W2022220426 hasConceptScore W2022220426C126322002 @default.
• W2022220426 hasConceptScore W2022220426C126894567 @default.
• W2022220426 hasConceptScore W2022220426C137061746 @default.
• W2022220426 hasConceptScore W2022220426C141071460 @default.
• W2022220426 hasConceptScore W2022220426C185592680 @default.
• W2022220426 hasConceptScore W2022220426C201750760 @default.
• W2022220426 hasConceptScore W2022220426C202751555 @default.
• W2022220426 hasConceptScore W2022220426C2776694085 @default.
• W2022220426 hasConceptScore W2022220426C2776738589 @default.
• W2022220426 hasConceptScore W2022220426C2776755627 @default.
• W2022220426 hasConceptScore W2022220426C2777371436 @default.
• W2022220426 hasConceptScore W2022220426C2777767877 @default.
• W2022220426 hasConceptScore W2022220426C2778119113 @default.
• W2022220426 hasConceptScore W2022220426C2778488018 @default.
• W2022220426 hasConceptScore W2022220426C2779171977 @default.
• W2022220426 hasConceptScore W2022220426C28328180 @default.
• W2022220426 hasConceptScore W2022220426C54355233 @default.
• W2022220426 hasConceptScore W2022220426C55493867 @default.
• W2022220426 hasConceptScore W2022220426C71924100 @default.
• W2022220426 hasConceptScore W2022220426C86803240 @default.
• W2022220426 hasConceptScore W2022220426C89560881 @default.
• W2022220426 hasConceptScore W2022220426C90924648 @default.
• W2022220426 hasIssue "6" @default.
• W2022220426 hasLocation W20222204261 @default.
• W2022220426 hasLocation W20222204262 @default.
• W2022220426 hasOpenAccess W2022220426 @default.
• W2022220426 hasPrimaryLocation W20222204261 @default.
• W2022220426 hasRelatedWork W1988691661 @default.
• W2022220426 hasRelatedWork W1997879714 @default.
• W2022220426 hasRelatedWork W2005487010 @default.
• W2022220426 hasRelatedWork W2017352244 @default.
• W2022220426 hasRelatedWork W2022220426 @default.
• W2022220426 hasRelatedWork W2049602605 @default.
• W2022220426 hasRelatedWork W2074224183 @default.
• W2022220426 hasRelatedWork W2095233177 @default.
• W2022220426 hasRelatedWork W2462688999 @default.
• W2022220426 hasRelatedWork W2105288765 @default.
• W2022220426 hasVolume "5" @default.
• W2022220426 isParatext "false" @default.

• next